ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,552, issued on Aug. 5, was assigned to Sirnaomics Inc. (Germantown, Md.).
"Oligomeric compound for inhibiting expression of factor XI" was invented by Dmitry Samarsky (Gaithersburg, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Products, compositions, and their uses are provided. In particular, nucleic acid products that modulate, in particular interfere with or inhibit, Factor XI (FXI) gene expression are provided. The products can be oligomeric compounds that comprise at least a first region of linked nucleosides having at least a first nucleobase sequence that is at least partially complementary to at least a portion of RNA transcribed from a...